ABO1105

BIOLOGICAL2 trials

Sponsors

Suzhou Abogen Biosciences Co., Ltd.

Conditions

Respiratory Syncytial Virus

Phase 1

Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above

Active, not recruitingNCT07289503

Suzhou Abogen Biosciences Co., Ltd.Respiratory Syncytial Virus

Start: 2025-05-27End: 2026-06-27Updated: 2025-12-17

Phase 2

Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above

Active, not recruitingNCT07289542

Suzhou Abogen Biosciences Co., Ltd.Respiratory Syncytial Virus

Start: 2025-09-15End: 2027-10-15Target: 420Updated: 2025-12-17